Key facts
- It has raised $550K across 1 recorded rounds; the latest was Early Stage VC ($300K) in Nov 2025.
- Notable investors include MedTech Innovator, Auxilium Worcester, Cherrystone Angel Group, Massachusetts Life Sciences Center, Rally Ventures — 7 tracked in total.
- Akeyna has filed 1 Form D with the SEC, most recently Nov 2025 ($300K sold to 3 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Akeyna
Funding rounds
1 roundsAbout Akeyna
Developer of medical devices designed to improve the lives of patients by minimizing risks associated with medical injections. The company's needle detects blood vessels to prevent severe complications such as blindness, which can occur when blood vessels are accidentally occluded with dermal fillers, enabling patients and physicians with improved medical technology.
- Sector
- Healthcare
- HQ
- Arlington, MA, United States
- Founded
- 2022
- Website
- akeynamedical.com/
- Ownership
- Privately Held (backing)
Akeyna doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Akeyna shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Akeyna in its N-PORT filings yet. We sweep new filings monthly.